Contact Lens Sensor Safe for Patients With Thyroid Eye Disease

This article originally appeared here.
Share this content:
Contact Lens Sensor Safe for Patients With Thyroid Eye Disease
Contact Lens Sensor Safe for Patients With Thyroid Eye Disease

TUESDAY, April 7, 2015 (HealthDay News) -- For patients with thyroid eye disease (TED), a contact lens sensor provides a safe and well-tolerated approach for 24-hour intraocular pressure (IOP) monitoring, according to a study published in the March issue of Clinical & Experimental Ophthalmology.

Anjali S. Parekh, M.D., from the University of California in San Diego, and colleagues conducted a prospective study in 10 patients with established TED (mean age, 61.8 years; 90 percent female) to examine the safety, tolerability, and 24-hour IOP patterns using a contact lens sensor. The authors assessed the incidence of adverse events and tolerability (scale of 0 to 10, increasing intolerance); a cosinor rhythmometry model was used to assess IOP patterns.

The researchers found that the main adverse events were blurred vision, conjunctival hyperemia, and superficial punctate keratitis (50, 100, and 20 percent, respectively). The lens tolerability was found to be 1.5 ± 0.7. Using a contact lens sensor signal, positive linear slopes were detected from wake to sleep (P = 0.254), whereas there was a significant decrease at the transition from sleep/supine to wake/sitting (P = 0.010). A significant nocturnal/sleep acrophase was seen in five patients, with the peak occurring at 6:30 a.m. The 24-hour curves had a mean amplitude of 102.2 ± 52.6 a.u.

"The contact lens sensor provides a safe and well-tolerated approach to 24-hour IOP monitoring," the authors write.

Several authors disclosed financial ties to medical device companies, including Sensimed AG, which funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Dupilumab Reduces Rate of Severe Asthma Exacerbations

Dupilumab Reduces Rate of Severe Asthma Exacerbations

And, add-on dupilumab reduces glucocorticoid dose in patients with glucocorticoid-treated asthma

Better Social Support Network Protects Black Men Against HIV

Better Social Support Network Protects Black Men Against ...

Social networks of black men who have sex with men influence HIV risk behavior

Recommendations Developed for Managing Postpartum Pain

Recommendations Developed for Managing Postpartum Pain

Impact of medications on mother-infant dyad should be considered, as many women breastfeed

is free, fast, and customized just for you!

Already a member?

Sign In Now »